Oct 19, 2023, 09:03 AM by

Addition brings together synchronized experts to offer comprehensive predictive analytics, data visualization and AI-driven end-to-end solutions for life sciences, government and non-profit organizations

Oct 18, 2023, 08:59 AM by

Servier partners with Owkin with the aim of discovering and developing AI-driven precision therapeutics. The multi-year agreement will use Owkin’s sophisticated AI to potentially enable Servier to develop novel therapeutics across various disease areas.

Oct 18, 2023, 08:59 AM by

Oct 18, 2023, 01:00 AM by User Not Found

Bio-IT World| A new preclinical system put to the test by a network of labs to adaptively study a handful of stroke treatments has succeeded in demonstrating that high-quality science is “feasible, practical, and less expensive than doing things the wrong way.”

Oct 17, 2023, 08:34 AM by

Oct 17, 2023, 08:34 AM by

Oct 17, 2023, 08:30 AM by

Discovery Park, Kent’s thriving life science community, has partnered with scientific content discovery and discussion platform, Researcher, to promote collaboration and facilitate scientific progress.

Oct 17, 2023, 08:30 AM by

ISPE has recognized Genentech as the 2023 Facility of the Year Awards (FOYA) Overall Winner for the Clinical Supply Center (CSC) project located in South San Francisco, California, USA.

Oct 16, 2023, 14:23 PM by User Not Found

Bio-IT World| The European Commission (EC), under the EU Merger Regulation (EUMR), released a statement last week announcing it has taken restorative measures that require Illumina to unwind its acquisition of GRAIL. The acquisition was completed before the EC provided approval, breaching EU merger control rules.

Oct 16, 2023, 08:50 AM by

When cfDNA testing result is negative or patients become unresponsive/resistant to current existing treatment strategy, plasma-based cfmRNA testing (ie., OncoDxRx’s PGA assay) can help clinicians to select the most effective therapy available within 5 days. Particularly in advanced cases of cancer, wait times associated with complex NGS testing of cfDNA can significantly impact a patient’s time to treatment and overall outcome.

Oct 16, 2023, 08:50 AM by

Oct 16, 2023, 08:50 AM by

Huateng Pharma, a leading pharmaceutical ingredient manufacturer, has introduced a new product line, Gastrointestinal API Intermediates, featuring Fexuprazan and Vonoprazan Intermediates. These intermediates are designed to meet the increasing demand for high-quality solutions in gastrointestinal therapy. The products are available in both GMP and Non-GMP grades, boasting exceptional purity to facilitate the production of top-tier pharmaceuticals.

Oct 16, 2023, 08:50 AM by

Growing number of infectious diseases, rise in R&D expenses in the pharma and biopharma segment, growing popularity of biologics & personalized medicine, innovations in analytical methods, and the trend of firms quickly outsourcing the bioanalytical services are the major factors triggering the bioanalytical services market growth.

Oct 16, 2023, 08:50 AM by

Oct 16, 2023, 08:50 AM by

Biopharma PEG announces a robust inventory of monodispersed PEGs, including mPEG36-NH2, NH2-PEG24-COOH, and more, catering to the pharmaceutical industry's diverse needs. These high-purity products, certified under EXCIPACT GMP standards with purity exceeding 95%, are ideal for ADCs, PROTACs, and drug delivery systems, reinforcing Biopharma PEG as a top-tier provider for pharmaceutical researchers and developers.

Oct 16, 2023, 08:50 AM by

A Plenary Keynote address on the first learnings of the $50 million MOSAIC initiative, whose goal is to revolutionize cancer research through spatial omics technologies, will kick off Bio-IT World Conference & Expo Europe, taking place 29-30 November in London.

Oct 16, 2023, 08:49 AM by

Creative Diagnostics has recently announced the launch of its new Checkerboard Assay services to support researchers.

Oct 16, 2023, 08:49 AM by

HighRun DataScience announced the launch of its new data science platform.

Oct 16, 2023, 08:49 AM by

Pioneering AI solutions and a commitment to industry-wide RBQM advancement secures CluePoints a finalist position in the 2023 SCRIP Awards RBQM leader recognized in Specialist Providers Category at Citeline’s SCRIP Awards

Oct 16, 2023, 08:49 AM by

IntelliGuard expands to Ohio and Canada and further invests in company sales team, with the goal to provide stronger customer engagement and support